Holen Sie sich die Stockscreener-App
75.15
0.13%
0.10
Handel nachbörslich:
74.96
-0.19
-0.25%
Schlusskurs vom Vortag:
$75.05
Offen:
$75.05
24-Stunden-Volumen:
3.79M
Relative Volume:
1.32
Marktkapitalisierung:
$16.78B
Einnahmen:
$4.13B
Nettoeinkommen (Verlust:
$543.90M
KGV:
31.18
EPS:
2.41
Netto-Cashflow:
$957.20M
1W Leistung:
-0.34%
1M Leistung:
-0.07%
6M Leistung:
+10.08%
1J Leistung:
+21.25%
1-Tages-Spanne:
$75.03
$75.20
1-Wochen-Bereich:
$75.00
$75.49
52-Wochen-Spanne:
$51.90
$75.75
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
75.15 | 16.78B | 4.13B | 543.90M | 957.20M | 2.41 |
|
ISRG
Intuitive Surgical Inc
|
477.73 | 171.69B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
158.08 | 45.59B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.74 | 37.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.26 | 33.89B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
227.88 | 33.59B | 5.40B | 1.49B | 1.78B | 10.12 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-12 | Herabstufung | Argus | Buy → Hold |
| 2026-01-05 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-11-21 | Herabstufung | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Hochstufung | Argus | Hold → Buy |
| 2025-08-06 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-05-27 | Bestätigt | Needham | Hold |
| 2025-03-03 | Herabstufung | Argus | Buy → Hold |
| 2025-02-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Herabstufung | Needham | Buy → Hold |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
Is Hologic Stock Outperforming the Dow? - Yahoo Finance
Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase? - TradingView
Mammography Devices Market Poised for Robust Growth at 8.25% - openPR.com
Aug PreEarnings: How is Hologic Inc managing supply chain issuesGold Moves & Expert Curated Trade Setups - baoquankhu1.vn
1,5 Milliarden Frauen verpassen wichtige Vorsorgeuntersuchungen – trotz weltweit steigender Screening-Raten - Eagle-Tribune
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates - Hologic
Sectra acquiring Oxipit | RadNet's $300M in 2026 acquisitions | Hologic clears hurdle in $18B sale to PE | More - Radiology Business
Technical Reactions to HOLX Trends in Macro Strategies - Stock Traders Daily
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests - MSN
Why Hologic Just Hit Your Health And Money Feeds At Once - AD HOC NEWS
Mackenzie Financial Corp Sells 141,733 Shares of Hologic, Inc. $HOLX - MarketBeat
Sexually Transmitted Disease Testing Market size to exceed - openPR.com
Natixis Advisors LLC Acquires 82,894 Shares of Hologic, Inc. $HOLX - MarketBeat
What Drives Hologic's GYN Surgical Strength in a Competitive Market? - The Globe and Mail
Dimensional Fund Advisors LP Has $155.75 Million Position in Hologic, Inc. $HOLX - MarketBeat
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
What Factors Contribute to Hologic's GYN Surgical Success Amidst Market Competition? - Bitget
Hologic, Inc. Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo
BioZorb Lawsuit and Settlement Information: March 2026 - AboutLawsuits.com
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - sharewise.com
Hologic, Inc. $HOLX Shares Bought by Crossmark Global Holdings Inc. - MarketBeat
Here’s What You Should Understand Besides the Fact That Hologic, Inc. (HOLX) is Gaining Attention - Bitget
Munich Reinsurance Co Stock Corp in Munich Purchases Shares of 61,962 Hologic, Inc. $HOLX - MarketBeat
Hologic, Inc. Hits New 52-Week High at $75.75, Reflecting Strong Performance - Markets Mojo
Hologic's Diagnostics Strength in Focus: Is More Upside Ahead? - Yahoo Finance
Aug Levels: Does Hologic Inc have a sustainable dividendJuly 2025 Drop Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Allegations of Toxic Leadership and Corruption in Hologic’s HR Department Raise Concerns About Workplace Culture - geneonline.com
Hologic Shares Edge Up 0.11% as Trading Volume Surges 149.8% to Rank 295th - Bitget
Hologic stock hits 52-week high at 75.49 USD By Investing.com - Investing.com Nigeria
Hologic, Inc. Hits New 52-Week High of $75.69, Marking Strong Growth - Markets Mojo
Trading the Move, Not the Narrative: (HOLX) Edition - Stock Traders Daily
GW&K Investment Management LLC Grows Stock Holdings in Hologic, Inc. $HOLX - MarketBeat
Bone Densitometer Market Set to Witness Rapid Growth Through - openPR.com
AustralianSuper Pty Ltd Has $5.56 Million Stock Holdings in Hologic, Inc. $HOLX - MarketBeat
Hologic stock hits 52-week high at 75.49 USD - Investing.com South Africa
Bone Sonometers Market Set to Witness Rapid Growth Through 2033 | - openPR.com
HOLX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Hologic, Inc. $HOLX Stock Holdings Decreased by Black Creek Investment Management Inc. - MarketBeat
Elo Mutual Pension Insurance Co Has $2.90 Million Stock Holdings in Hologic, Inc. $HOLX - MarketBeat
Black Creek Investment Management Reduces Hologic Stake - National Today
Aug Movers: Is Hologic Inc part of any ETFMarket Trend Review & Real-Time Volume Analysis - baoquankhu1.vn
Hologic (NASDAQ:HOLX) Sets New 1-Year HighStill a Buy? - MarketBeat
Hologic, Inc. $HOLX Shares Sold by Victory Capital Management Inc. - MarketBeat
Becker Capital Management Inc. Boosts Holdings in Hologic, Inc. $HOLX - MarketBeat
Hologic (HOLX) director awarded 3,190 restricted stock units of common stock - Stock Titan
Director at Hologic (HOLX) receives 3,190 restricted stock units award - Stock Titan
Hologic (HOLX) general counsel logs small tax share withholding - Stock Titan
Director Amy McBride granted 3,190 RSUs at Hologic (HOLX) in Form 4 filing - Stock Titan
Director at Hologic (HOLX) awarded 3,190 restricted stock units - Stock Titan
Hologic (HOLX) director granted 3,190 RSUs vesting at 2027 meeting - Stock Titan
Hologic (HOLX) director Nanaz Mohtashami receives 3,190 restricted stock units - Stock Titan
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):